Allergan IBS treatments focus of poster presentations at ACG Scientific Meeting

Allergan had data from its IBS portfolio featured in two poster presentations.
Allergan had data from its IBS portfolio featured in two poster presentations. | File photo
Recent data from Allergan's range of irritable bowel syndrome treatments were the focus of two poster presentations at the American College of Gastroenterology (ACG) Annual Scientific Meeting.
The ACG Annual Scientific Meeting was held Oct. 14-19 in Las Vegas with the poster presentations held in the Venetian Hotel exhibit hall.
Allergan is a global leader in the pharmaceutical industry that is dedicated to the research and development of new gastrointestinal disease treatments.